Schistosomiasis Diseases Market to Grow at a CAGR of 4% by 2029 | Industry Trends, Size, Share, Demand, Growth Drivers, and Competitive Landscape

The expected CAGR of global schistosomiasis diseases market is tend to be around 4% in the mentioned forecast period. The market was valued at USD 70 million in 2021, and it would grow upto USD 95.80 million by 2029.

Schistosomiasis is also known as bilharzia, a tropical disease caused by a group of parasitic worms called blood flukes belonging to the genus Schistosoma. The disease is transmitted through the consumption of freshwater infected from the larva of parasitic worms. This parasite penetrates into the human skin to reach blood stream and travel to the liver, intestine and other organs. The characteristics sign and symptoms of the abdominal pain, chills and fatigue.

Browse More About This Research Report @
https://www.databridgemarketresearch.com/reports/global-schistosomiasis-diseases-market

Some of the major players operating in the Schistosomiasis Diseases market report are Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Abbvie, Inc (U.S.), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Cipla Inc. (U.S.), Abbott (U.S.), Bausch Health Companies Inc. (Canada), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), Amneal Pharmaceuticals LLC. (U.S.), Seagen, Inc (U.S.), ONO Pharmaceutical Co., Ltd. (Japan) among others.

Competitive Landscape and Global Schistosomiasis Diseases Market Share Analysis :

The schistosomiasis diseases market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to schistosomiasis diseases market.

Browse Trending Reports:

https://dbmr064rs.blogspot.com/2025/03/laser-phosphor-display-lpd-market.html

https://dbmr064rs.blogspot.com/2025/02/antibiotics-in-animal-feed-market.html

https://dbmr064rs.blogspot.com/2025/02/flaxseed-market-overview-trends.html

https://dbmr064rs.blogspot.com/2025/03/digital-identity-solution-market.html

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Contact Us: -

Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC: +653 1251 1177
Email: - sopan.gedam@databridgemarketresearch.com

This release was published on openPR.